ロード中...
Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
BACKGROUND: Cigarette smoking has emerged as a leading cause of mortality among people with hepatitis C virus (HCV). People who inject drugs (PWID) represent the largest group of adults infected with HCV in the US. However, cigarette smoking remains virtually unexplored among this population. This s...
保存先:
| 出版年: | BMC Infect Dis |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7718688/ https://ncbi.nlm.nih.gov/pubmed/33276738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05667-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|